.jpg "Amy Alston, Pharm.D., MS photo")
Medical Associate Director, Nanomedicine
CSL Vifor
Dr. Amy Barton Alston is a nephrology-trained clinical pharmacist. Prior to joining CSL Vifor as the Medical Associate Director for Nanomedicine, Dr. Alston had a 20+ year career as an academic researcher focused on translational investigations of intravenous iron-carbohydrate nanomedicines in the chronic kidney disease population. She was previously funded by the Food and Drug Administration to advance bioequivalence evaluation for intravenous iron-carbohydrate nanomedicines using in vitro and pre-clinical models. During her tenure as an academician, Dr. Alston maintained a clinical practice providing care to patients across the chronic kidney disease continuum with a focus on the in-center hemodialysis population. Dr. Alston holds a Master’s degree in Healthcare Innovation and is a fellow of the American Society of Nephrology, National Kidney Foundation and the American College of Clinical Pharmacy.